Aviana Molecular Technologies (AMT) is a development stage company focused on marketing a new generation of innovative, highly sensitive and specific, State-of-the-Art Biosensors specifically targeting point-of-care (POC) diagnostic products for human healthcare and veterinary medicine. AMT’s focus is to identify areas in POC with high unmet needs in the US and around the world, where POC diagnosis can make a difference in human health. AMT’s biosensor technology is based on an innovative and proprietary adaptation of the commonly used surface acoustic wave sensors (SAW) with critical changes that make this technology applicable as a biosensor. Further innovation allows AMT’s biosensor to be used to diagnose multiple diseases and biomarkers in one chip using an entirely electronics-based system for readouts.

University Partners: Temple University